somatostatin analogTherapeutic Peptides
Pasireotide (Signifor)
A cyclohexapeptide somatostatin analog with high affinity for SSTR1,2,3,5. FDA-approved for Cushings disease and acromegaly. Broader receptor binding profile than octreotide or lanreotide.
cushings-diseaseacromegalysomatostatin-analogFDA-approved
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity dataLab Reports
0 reports on file
Summary
A cyclohexapeptide somatostatin analog with high affinity for SSTR1,2,3,5. FDA-approved for Cushings disease and acromegaly. Broader receptor binding profile than octreotide or lanreotide.